Similar articles

• Purine phosphoribosyltransferase in gilles de la Tourette syndrome.

  Van Woert MH, Yip LC, Balis ME. Van Woert MH, et al. N Engl J Med. 1977 Jan 27;296(4):210-2. doi: 10.1056/NEJM197701272960409. N Engl J Med. 1977. PMID: 299777 No abstract available.
• Hypoxanthine guanine phosphoribosyltransferase (HGPRT) in Gilles de la Tourette syndrome.

  Merril CR, Leavitt J, Van Keuren ML, Ebert MH, Caine ED. Merril CR, et al. Neurology. 1979 Jan;29(1):131-4. doi: 10.1212/wnl.29.1.131. Neurology. 1979. PMID: 284202
• Gilles de la Tourette syndrome: further studies and thoughts.

  Singer HS, Pepple JM, Ramage AL, Butler IJ. Singer HS, et al. Ann Neurol. 1978 Jul;4(1):21-5. doi: 10.1002/ana.410040105. Ann Neurol. 1978. PMID: 279303
• Gilles de la Tourette syndrome: etiologic considerations.

  Eldridge R, Denckla MB. Eldridge R, et al. Rev Neurol (Paris). 1986;142(11):833-9. Rev Neurol (Paris). 1986. PMID: 3547548 Review.
• [Gilles de la Tourette syndrome].

  Grønbech-Jensen M. Grønbech-Jensen M. Ugeskr Laeger. 1993 Nov 15;155(46):3759-63. Ugeskr Laeger. 1993. PMID: 8256371 Review. Danish.